NCT06246149
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06246149
Title Adjuvant Tebentafusp in High Risk Ocular Melanoma (ATOM)
Acronym ATOM
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications
Therapies
Age Groups: senior | adult
Covered Countries POL | NLD | GBR | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Cliniques Universitaires Saint-Luc RECRUITING Brussels 1200 Belgium Details
Institut Curie - Hôpital de Paris RECRUITING Paris 75248 France Details
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin RECRUITING Berlin 12200 Germany Details
Universitaets Krankenhaus Eppendorf - Universitaetsklinikum Hamburg-Eppendorf KE - University Cancer Center RECRUITING Hamburg 20246 Germany Details
Universitaetsklinikum Heidelberg - Frauenklinik / Hautklinik RECRUITING Heidelberg DE 69120 Germany Details
Leiden University Medical Centre RECRUITING Leiden 2300 Netherlands Details
Maria Sklodowska-Curie Memorial Cancer Centre - Maria Sklodowska-Curie National Research Institute of Oncology RECRUITING Warsaw 02 781 Poland Details
Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) RECRUITING L'Hospitalet de Llobregat 08908 Spain Details
Hospital Clinico Universitario De Valladolid RECRUITING Valladolid 47003 Spain Details
East and North Hertfordshire NHS Trust - Mount Vernon Hospital RECRUITING Northwood HA6 2RN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field